NASDAQ:EYES – State Reviewer

Markets

Is Second Sight Medical Products Inc. (NASDAQ:EYES) Still Worth A Bite?

Second Sight Medical Products Inc. (NASDAQ:EYES) previous close was $7.00 while the outstanding shares total 23.54M. The firm has a beta of 3.41. EYES’s shares

Markets

Can Second Sight Medical Products Inc. (NASDAQ:EYES) Offer Investors Safety?

Second Sight Medical Products Inc. (NASDAQ:EYES) previous close was $6.28 while the outstanding shares total 23.54M. The firm has a beta of 3.42. EYES’s shares

Finance

EYES Stock: Second Sight Medical Products Inc. (NASDAQ:EYES) Is Still Worth a Bite

Second Sight Medical Products Inc. (NASDAQ:EYES) has a beta of 3.43. The stock’s Relative Strength Index (RSI) is 61.02, with weekly volatility at 15.86% and

Finance

EYES Stock: Second Sight Medical Products Inc. (NASDAQ:EYES) Is Still Worth a Bite

Second Sight Medical Products Inc. (NASDAQ:EYES) Relative Strength Index (RSI) is 44.70, with weekly volatility at 10.07% and ATR at 0.62. The EYES stock’s 52-week

Markets

Second Sight Medical Products Inc. (NASDAQ:EYES): The Fundamentals Have Changed

Second Sight Medical Products Inc. (NASDAQ:EYES) Relative Strength Index (RSI) is 37.10, with weekly volatility at 9.96% and ATR at 0.69. The EYES stock’s 52-week

Tag: NASDAQ:EYES

Is Second Sight Medical Products Inc. (NASDAQ:EYES) Still Worth A Bite?

Can Second Sight Medical Products Inc. (NASDAQ:EYES) Offer Investors Safety?

EYES Stock: Second Sight Medical Products Inc. (NASDAQ:EYES) Is Still Worth a Bite

EYES Stock: Second Sight Medical Products Inc. (NASDAQ:EYES) Is Still Worth a Bite

Second Sight Medical Products Inc. (NASDAQ:EYES): The Fundamentals Have Changed

Quick Links

Categories